Goldman Sachs Knock-Out GS7/ DE000GA9SDF7 /
5/20/2022 6:31:00 PM | Chg.+0.040 | Bid9:57:23 PM | Ask9:57:23 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.750EUR | +5.63% | 0.760 Bid Size: 100,000 |
0.770 Ask Size: 100,000 |
GSK PLC L... | 11.198 - | 12/31/2078 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...